CPRiL

C27H45N3O6

CCCCCCCC/C=C/CCCCCCCC(=O)OC[C@@H]1[C@H]([C@@H]([C@@H](O1)N2C=CC(=NC2=O)N)O)O

InChI=1S/C27H45N3O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-23(31)35-20-21-24(32)25(33)26(36-21)30-19-18-22(28)29-27(30)34/h9-10,18-19,21,24-26,32-33H,2-8,11-17,20H2,1H3,(H2,28,29,34)/b10-9+/t21-,24-,25+,26-/m1/s1

• Elacytarabine
• 188181-42-2
• CP-4055
ELACYT
CP 4055
TA7WJG93AR
Elacytarabine [USAN:INN]
Elacytarabine [INN]
Elacitarabina
P-4055
ELACYTARABINE [USAN]
ELACYTARABINE [WHO-DD]
2(1H)-Pyrimidinone, 4-amino-1-(5-O-((9E)-1-oxo-9-octadecenyl)-beta-D-arabinofuranosyl)-
5'-O-(TRANS-9''-OCTADECENOYL)-1-SS-D-ARABINOFURANOSYL CYTOSINE
4-AMINO-1-(5-O-((9E)-OCTADEC-9-ENOYL)-.BETA.-D-ARABINOFURANOSYL)PYRIMIDIN-2(1H)-ONE
2(1H)-PYRIMIDINONE, 4-AMINO-1-(5-O-((9E)-1-OXO-9-OCTADECEN-1-YL)-.BETA.-D-ARABINOFURANOSYL)-
2(1H)-PYRIMIDINONE, 4-AMINO-1-(5-O-((9E)-1-OXO-9-OCTADECENYL)-.BETA.-D-ARABINOFURANOSYL)-
elacytarabinum
4-AMINO-1-(5-O-((9E)-OCTADEC-9-ENOYL)-BETA-D-ARABINOFURANOSYL)PYRIMIDIN-2(1H)-ONE
4-amino-1-[5-O-[(9E)-octadec-9-enoyl]-beta-D-arabinofuranosyl]pyrimidin-2(1H)-one
((2R,3S,4S,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl)methyl (9E)-octadec-9-enoate
[(2R,3S,4S,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (9E)-octadec-9-enoate
2(1H)-PYRIMIDINONE, 4-AMINO-1-(5-O-((9E)-1-OXO-9-OCTADECEN-1-YL)-BETA-D-ARABINOFURANOSYL)-
675837-43-1
101235-34-1
UNII-TA7WJG93AR
[(2R,3S,4S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (E)-octadec-9-enoate
5'-O-(Elaidoyl) 1-beta-D-arabinofuranosylcytosine
5/'-oleoyl cytarabine
CP4055